Epidermal Langerhans cells from mice bearing a granulocyte macrophage-colony stimulating factor-producing mammary tumor display impaired accessory functions

Anticancer Research

Volumn 16, Issue 1, 1996, Pages 9-16

  Xie, Yong ^a   Fernandez, Mary E ^b   Streilein, J Wayne ^a   Lopez, Diana M ^b,c  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Accessory functions, or derived factors; Epidermal Langerhans cells

Indexed keywords

ANTIBODY; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOMETACIN; PROSTAGLANDIN E2; SUPERANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CELL PROLIFERATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; FLOW CYTOMETRY; KERATINOCYTE; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADENOCARCINOMA; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; DOWN-REGULATION; ENTEROTOXINS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; LANGERHANS CELLS; LYMPHOCYTE ACTIVATION; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SKIN; SKIN PHYSIOLOGY; T-LYMPHOCYTES;

EID: 0029929496     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fu Y-X, Paul RD, Wang Y and Lopez DM: Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas. J Immunol 143: 4300-4307, 1989.
2. Lopez DM, Fu Y-X, Watson GA, Sotomayor E, Lopez-Cepero M and Ganju A: Modulation of the immune system of mammary tumor-derived factors. Cancer Invest 9, 643-653, 1991.
3. Sotomayor EM, Fu Y-X, Lopez-Cepero M, Herbert L, Jimenez JJ, Albarracin C and Lopez DM: Role of tumor derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor derived granulocyte-macrophage colony stimulating factor. J Immunol 147 2816-2823, 1991.
4. Watson GA, Fu Y-X and Lopez DM: Splenic macrophages from tumor bearing mice coexpressing Mac-1 and Mac-2 antigens exert immunoregulatory functions via distinct mechanisms. J Leuk Biol 49: 126-138, 1991.
5. Wells SA, Burdick JF, Joseph WL, Christiansen CL, Wolfe WG and Adkins PC: Delayed cutaneous hypersensitivity rections to tumor antigens and to non-specific antigens; prognostic significance in patients with lung cancer. J Thorac Cardiovasc Surg 66: 557-562, 1973.
6. Streilein JW and Bergstresser PR: Langerhans cell function dictates induction of contact hypersensitivity or unresponsiveness to DNCB in Syrian hamsters. J Invest Dermatol 77: 272-277, 1981.
7. Stingl G, Hauser E, Tschachler E, Groh V, and Wolff K: Immune functions of epidermal cells. In: Immune Mechanisms in Cutaneous Disease (Norris DA, ed). New York, Marcel Dekker, 1989, pp 3-72.
8. Grabbe S, Gallo RL, Lindgren A, and Granstein RD: Deficient antigen presentation by Langerhans cells from athymic (nu/nu) mice. J Immunol 151: 3430-3439, 1993.
9. Streilein JW and Grammar SF: In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes. J Immunol 143: 3925-3933, 1989.
10. Streilein JW, Grammar SF, Yoshikawa T, Demiden A, and Vermeer M: Functional dichotomy between Langerhans cells that present antigen to native and to memory/effector T lymphocytes. Immunological Rev 117: 159-183, 1990.
11. Dai R, Grammar SF, and Streilein JW: Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells. J Immunol 150: 59-66, 1993.
12. Schuler G and Steinman RM: Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 161, 526-546, 1985.
13. Koch F, Heufler C, Kampgen E, Schnecweiss D, Bock G, and Schuler G: Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation. J. Exp. Med. 171: 159-171, 1990.
14. Witmer-Pack MD, Schuler G, and Steinman RM: Granulocyte-Macrophage colonystimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 166: 1484-1498, 1987.
15. Tsuchiya Y, Igarashi M, Suzuki R, and Kumagai RK: Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells. J Immunol 141: 699-708, 1988.
16. Fu Y-X, Watson G, Jimenez JJ, Wang Y and Lopez DM: Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. Cancer Res. 50: 227-234, 1990.
17. Fu Y-X, Watson GA, Kasahara M, and Lopez DM: The role of tumor derived cytokines on the immune system of mice bearing mammary adenocarcinomas. I. Induction of regulatory macrophages by in vivo administration of rGM-CSF. J Immunol 146: 783-789, 1991.
18. Medina D and DeOme KB: Response of hyperplastic alveolar nodule outgrowth line D1 to mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation acting singly and in combination. J Natl Cancer Inst 42: 303-309, 1969.
19. Shimonkevitz R, Kappler J, Marrack P, and Grey H: Antigen recognition by H-2 restricted T cells. Cell-free antigen processing. J Exp Med 158: 303-316, 1983.
20. Mollick JA, Cook RG, and Rich RR: Class II MHC are specific receptors for Staphylococcus enterotoxin A. Science 255: 817-819, 1992.
21. Calderon C, Huang Z-H, Gage DA, Sotomayor EM, and Lopez DM: Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine. J Exp Med 180: 945-958, 1994.
22. Paul RD, Ghaffar A, Sigel MM, Charyulu V, and Lopez DM: Splenic alterations during mammary tumorigenesis. Diverse effects on different immune parameters. Anticancer Res. 1: 63-69, 1981.
23. Grabbe S, Bruvers S, Beissert S, and Granstein RD: Interferon-γ inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Leuk Biol 55: 695-701, 1994.
24. Sotomayor EM, Cheng X-F, Fu Y-X, Hawkins A, Calderon-Higginson C, and Lopez DM: Impaired activation of tumoricidal function in macrophages from mammary tumor bearers: The role of IFN- γ. Int J Oncology 3: 719-727, 1993.
25. Handel ME and Lopez DM: Effects of tumor derived GM-CSF on cytokine production by macrophages: Possible role in cachexia Abs. 12th European Immunol. Meeting, p. 208, 1994.
26. Tan K-C, Hosoi J, Grabbe S, Asahina A: and Granstein RD: Epidermal cell presentation of tumor-associated antigens for induction of tolerance. J Immunol 153 760-767, 1994.